Ilshin Bio: 2025 Financial Turnaround Insights
As of November 21, 2025, Ilshin Bio’s share price is KRW 1,852, up 15.5%, with a market cap of KRW 81.9 billion. Despite experiencing revenue declines, signs of recovery emerged in 2025, marked by increased profits and order backlog. Valuations appear reasonable with potential for growth dependent on demand in bio infrastructure and market themes.